COMMUNIQUÉS West-GlobeNewswire

Acer Therapeutics Announces Pricing of Underwritten Public Offering
01/08/2018
NEWTON, Mass., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Zynerba Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference
01/08/2018
DEVON, Pa., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Tauriga Sciences Inc. Reports Quarterly Net Profit of $166,788 for its 1st Fiscal Quarter of 2019
01/08/2018
NEW YORK, NY, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB: TAUG) (OTCQB: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
CV Sciences, Inc. Reports Second Quarter 2018 Financial Results
01/08/2018
Growth and Profitability Driven by Key Financial Performance Metrics, including Record GAAP Net Income of $3.2 Million Management to Host Second Quarter 2018 Financial Results Conference Call on August 1, 2018 at 4:15pm [...]
Bellerophon Provides Business Update and Reports Second Quarter 2018 Financial Results
01/08/2018
WARREN, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]
Scythian Invests in PRØHBTD, a Leading Global Cannabis Media Platform
01/08/2018
TORONTO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) today announced it has invested in and entered into a [...]
Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate
01/08/2018
MADISON, Wis. and COURBEVOIE, France, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of [...]
AzurRx BioPharma to Present at the 2018 Cannacord Genuity 38th Annual Growth Conference (August 9th)
01/08/2018
BROOKLYN, N.Y., Aug. 01, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Pure Global Cannabis Poised To Launch Canada's First Multi-Ponic Cannabis Farm -- CFN Media
01/08/2018
SEATTLE, Aug. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
RedHill Biopharma Elaborates on Its Announced Positive Top-Line Results from Phase III Study of RHB-104 in Crohn’s Disease
01/08/2018
TEL-AVIV, Israel and RALEIGH, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
GTX Corp Signs Agreement and Forms Alliance with Autism Society of America
01/08/2018
LOS ANGELES, Aug. 01, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announced the [...]
Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer
01/08/2018
SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that Steven G. Hughes has been named Chief Medical Officer. Dr. Hughes is an industry veteran who brings [...]
Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018
01/08/2018
CORAL GABLES, Fla., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Foamix Pharmaceuticals to Announce Second Quarter Financial Results on August 8
01/08/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018
01/08/2018
BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]
Andrea Hartong, CNOR, CLNC is Elected to the American Health Council’s Nurse Board
01/08/2018
NEW YORK, Aug. 01, 2018 (GLOBE NEWSWIRE) -- The American Health Council proudly announces the election of Andrea Hartong, CNOR, CLNC to their Nursing Board for her examples of healthcare excellence. For the past 20 [...]
Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018
01/08/2018
COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Next Generation nVNS Therapy gammaCore Sapphire™ Now Available for Patients with Migraine and Episodic Cluster Headache in United States
01/08/2018
Innovative technology provides patients with convenient, easy-to-use treatment option without the potential side effects associated with commonly prescribed medicines BASKING RIDGE, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE [...]
VBL Therapeutics to Report Second Quarter 2018 Financial Results on August 16
01/08/2018
TEL AVIV, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Pages